Antiresorptive therapy in asthmatic patients receiving high-dose inhaled steroids: A prospective study for 18 months
Open Access
- 1 April 1998
- journal article
- clinical trial
- Published by Elsevier in Journal of Allergy and Clinical Immunology
- Vol. 101 (4) , 445-450
- https://doi.org/10.1016/s0091-6749(98)70351-3
Abstract
No abstract availableKeywords
This publication has 23 references indexed in Scilit:
- Decreased Bone Mineral Density in Premenopausal Asthma Patients Receiving Long-term Inhaled SteroidsChest, 1994
- INTERMITTENT CYCLICAL ETIDRONATE IN THE PREVENTION OF CORTICOSTEROID-INDUCED BONE LOSSRheumatology, 1994
- Efficacy and Safety of Inhaled Corticosteroids in AsthmaAmerican Review of Respiratory Disease, 1993
- Effects of inhaled budesonide on serum markers of bone metabolism in children with asthmaJournal of Allergy and Clinical Immunology, 1992
- Inhaled beclomethasone decreases serum osteocalcin in postmenopausal asthmatic womenBone, 1992
- Effects of dose and dosing schedule of inhaled budesonide on bone turnoverJournal of Allergy and Clinical Immunology, 1991
- Adrenocortical suppression following treatment with beclomethasone and budesonideClinical and Experimental Allergy, 1991
- Effect of Intermittent Cyclical Etidronate Therapy on Bone Mass and Fracture Rate in Women with Postmenopausal OsteoporosisNew England Journal of Medicine, 1990
- Calcium supplements in the prevention of steroid-induced osteoporosisThe American Journal of Clinical Nutrition, 1986
- Radioactive Calcium Kinetics during High Calcium Intake in Osteoporosis*Journal of Clinical Investigation, 1965